Aytu Ptb Ratio vs Net Income Per Share Analysis

AYTU Stock

USD 1.30 0.05 3.70%

Aytu BioScience financial indicator trend analysis is way more than just evaluating Aytu BioScience prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aytu BioScience is a good investment. Please check the relationship between Aytu BioScience Ptb Ratio and its Net Income Per Share accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aytu BioScience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Aytu Stock please use our How to Invest in Aytu BioScience guide.

Ptb Ratio vs Net Income Per Share

Ptb Ratio vs Net Income Per Share Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aytu BioScience Ptb Ratio account and Net Income Per Share. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Aytu BioScience's Ptb Ratio and Net Income Per Share is -0.54. Overlapping area represents the amount of variation of Ptb Ratio that can explain the historical movement of Net Income Per Share in the same time period over historical financial statements of Aytu BioScience, assuming nothing else is changed. The correlation between historical values of Aytu BioScience's Ptb Ratio and Net Income Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ptb Ratio of Aytu BioScience are associated (or correlated) with its Net Income Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income Per Share has no effect on the direction of Ptb Ratio i.e., Aytu BioScience's Ptb Ratio and Net Income Per Share go up and down completely randomly.

Correlation Coefficient

-0.54

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Net Income Per Share

Most indicators from Aytu BioScience's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aytu BioScience current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aytu BioScience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Aytu Stock please use our How to Invest in Aytu BioScience guide.At this time, Aytu BioScience's Selling General Administrative is comparatively stable compared to the past year. Tax Provision is likely to gain to about 2.1 M in 2025, despite the fact that Enterprise Value Multiple is likely to grow to (358.17).

	2022	2023	2024	2025 (projected)
Gross Profit	66.6M	54.6M	62.8M	65.9M
Total Revenue	107.4M	81.0M	93.2M	97.8M

Gross Profit Total Revenue

Aytu BioScience fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock Total Equity	Other Current Assets	Common Stock	Net Tangible Assets	Current Deferred Revenue	Non Currrent Assets Other	Retained Earnings Total Equity
Total Assets		0.84	0.6	0.94	0.89	0.83	-0.52	-0.75	0.99	0.9	0.99	0.9	0.52	0.78	0.86	0.94	0.92	0.98	0.66	-0.44	0.64	-0.44	-0.31	0.83	0.56	-0.8
Short Long Term Debt Total	0.84		0.52	0.82	0.71	0.75	-0.37	-0.72	0.85	0.72	0.85	0.72	0.45	0.69	0.79	0.82	0.82	0.81	0.67	-0.74	0.51	-0.74	-0.45	0.74	0.61	-0.84
Other Current Liab	0.6	0.52		0.75	0.21	0.4	0.04	-0.94	0.7	0.35	0.5	0.34	0.89	0.85	0.9	0.81	0.64	0.71	-0.02	-0.36	0.94	-0.37	-0.6	0.77	0.84	-0.67
Total Current Liabilities	0.94	0.82	0.75		0.72	0.82	-0.22	-0.85	0.96	0.72	0.92	0.72	0.69	0.77	0.92	0.98	0.96	0.95	0.61	-0.41	0.69	-0.41	-0.56	0.94	0.7	-0.75
Total Stockholder Equity	0.89	0.71	0.21	0.72		0.78	-0.74	-0.41	0.83	0.96	0.93	0.96	0.11	0.5	0.55	0.69	0.73	0.82	0.74	-0.35	0.34	-0.35	0.06	0.58	0.19	-0.62
Property Plant And Equipment Net	0.83	0.75	0.4	0.82	0.78		-0.2	-0.57	0.79	0.68	0.88	0.67	0.2	0.46	0.62	0.76	0.93	0.75	0.73	-0.3	0.43	-0.29	-0.49	0.86	0.25	-0.59
Net Debt	-0.52	-0.37	0.04	-0.22	-0.74	-0.2		0.1	-0.47	-0.81	-0.52	-0.81	0.11	-0.39	-0.23	-0.28	-0.16	-0.5	-0.27	0.29	-0.2	0.29	-0.56	-0.01	0.04	0.47
Retained Earnings	-0.75	-0.72	-0.94	-0.85	-0.41	-0.57	0.1		-0.82	-0.53	-0.67	-0.52	-0.83	-0.91	-0.97	-0.91	-0.77	-0.82	-0.18	0.5	-0.9	0.5	0.65	-0.86	-0.82	0.85
Accounts Payable	0.99	0.85	0.7	0.96	0.83	0.79	-0.47	-0.82		0.86	0.96	0.86	0.6	0.82	0.91	0.97	0.91	0.99	0.58	-0.47	0.73	-0.47	-0.36	0.85	0.63	-0.83
Cash	0.9	0.72	0.35	0.72	0.96	0.68	-0.81	-0.53	0.86		0.9	1.0	0.24	0.66	0.64	0.74	0.68	0.87	0.59	-0.42	0.49	-0.42	0.07	0.58	0.31	-0.74
Non Current Assets Total	0.99	0.85	0.5	0.92	0.93	0.88	-0.52	-0.67	0.96	0.9		0.9	0.41	0.69	0.79	0.9	0.92	0.95	0.74	-0.43	0.54	-0.43	-0.29	0.81	0.47	-0.76
Cash And Short Term Investments	0.9	0.72	0.34	0.72	0.96	0.67	-0.81	-0.52	0.86	1.0	0.9		0.24	0.66	0.64	0.74	0.68	0.87	0.6	-0.43	0.49	-0.43	0.07	0.58	0.31	-0.74
Common Stock Shares Outstanding	0.52	0.45	0.89	0.69	0.11	0.2	0.11	-0.83	0.6	0.24	0.41	0.24		0.75	0.84	0.74	0.54	0.63	0.04	-0.29	0.73	-0.3	-0.57	0.63	0.93	-0.53
Non Current Liabilities Total	0.78	0.69	0.85	0.77	0.5	0.46	-0.39	-0.91	0.82	0.66	0.69	0.66	0.75		0.93	0.87	0.67	0.85	0.13	-0.5	0.88	-0.51	-0.39	0.7	0.75	-0.9
Other Stockholder Equity	0.86	0.79	0.9	0.92	0.55	0.62	-0.23	-0.97	0.91	0.64	0.79	0.64	0.84	0.93		0.97	0.84	0.92	0.32	-0.51	0.87	-0.52	-0.55	0.86	0.84	-0.86
Total Liab	0.94	0.82	0.81	0.98	0.69	0.76	-0.28	-0.91	0.97	0.74	0.9	0.74	0.74	0.87	0.97		0.93	0.97	0.51	-0.45	0.78	-0.46	-0.54	0.91	0.75	-0.83
Property Plant And Equipment Gross	0.92	0.82	0.64	0.96	0.73	0.93	-0.16	-0.77	0.91	0.68	0.92	0.68	0.54	0.67	0.84	0.93		0.88	0.68	-0.36	0.6	-0.36	-0.59	0.95	0.57	-0.7
Total Current Assets	0.98	0.81	0.71	0.95	0.82	0.75	-0.5	-0.82	0.99	0.87	0.95	0.87	0.63	0.85	0.92	0.97	0.88		0.54	-0.45	0.75	-0.45	-0.32	0.83	0.64	-0.83
Short Term Debt	0.66	0.67	-0.02	0.61	0.74	0.73	-0.27	-0.18	0.58	0.59	0.74	0.6	0.04	0.13	0.32	0.51	0.68	0.54		-0.3	-0.08	-0.3	-0.21	0.51	0.19	-0.3
Common Stock Total Equity	-0.44	-0.74	-0.36	-0.41	-0.35	-0.3	0.29	0.5	-0.47	-0.42	-0.43	-0.43	-0.29	-0.5	-0.51	-0.45	-0.36	-0.45	-0.3		-0.4	1.0	0.18	-0.34	-0.55	0.67
Other Current Assets	0.64	0.51	0.94	0.69	0.34	0.43	-0.2	-0.9	0.73	0.49	0.54	0.49	0.73	0.88	0.87	0.78	0.6	0.75	-0.08	-0.4		-0.4	-0.39	0.71	0.69	-0.74
Common Stock	-0.44	-0.74	-0.37	-0.41	-0.35	-0.29	0.29	0.5	-0.47	-0.42	-0.43	-0.43	-0.3	-0.51	-0.52	-0.46	-0.36	-0.45	-0.3	1.0	-0.4		0.19	-0.34	-0.56	0.68
Net Tangible Assets	-0.31	-0.45	-0.6	-0.56	0.06	-0.49	-0.56	0.65	-0.36	0.07	-0.29	0.07	-0.57	-0.39	-0.55	-0.54	-0.59	-0.32	-0.21	0.18	-0.39	0.19		-0.71	-0.52	0.38
Current Deferred Revenue	0.83	0.74	0.77	0.94	0.58	0.86	-0.01	-0.86	0.85	0.58	0.81	0.58	0.63	0.7	0.86	0.91	0.95	0.83	0.51	-0.34	0.71	-0.34	-0.71		0.62	-0.69
Non Currrent Assets Other	0.56	0.61	0.84	0.7	0.19	0.25	0.04	-0.82	0.63	0.31	0.47	0.31	0.93	0.75	0.84	0.75	0.57	0.64	0.19	-0.55	0.69	-0.56	-0.52	0.62		-0.61
Retained Earnings Total Equity	-0.8	-0.84	-0.67	-0.75	-0.62	-0.59	0.47	0.85	-0.83	-0.74	-0.76	-0.74	-0.53	-0.9	-0.86	-0.83	-0.7	-0.83	-0.3	0.67	-0.74	0.68	0.38	-0.69	-0.61

Click cells to compare fundamentals

Aytu BioScience Account Relationship Matchups

Aytu BioScience fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	265.7M	137.6M	136.5M	118.1M	135.8M	142.6M
Short Long Term Debt Total	28.3M	18.2M	16.4M	15.1M	17.4M	18.3M
Other Current Liab	7.4M	49.5M	55.5M	47.5M	54.7M	57.4M
Total Current Liabilities	109.4M	64.4M	69.0M	62.2M	71.6M	75.1M
Total Stockholder Equity	137.6M	46.1M	39.4M	27.7M	31.9M	24.5M
Property Plant And Equipment Net	8.7M	6.3M	3.9M	1.5M	1.8M	1.4M
Net Debt	(21.3M)	(1.2M)	(6.6M)	(4.9M)	(4.4M)	(4.6M)
Retained Earnings	(178.3M)	(288.5M)	(304.1M)	(320.0M)	(288.0M)	(273.6M)
Accounts Payable	19.3M	11.0M	13.5M	10.4M	12.0M	12.6M
Cash	49.6M	19.4M	23.0M	20.0M	23.0M	12.0M
Non Current Assets Total	160.4M	77.7M	63.6M	56.2M	64.6M	67.9M
Cash And Short Term Investments	49.6M	19.4M	23.0M	20.0M	23.0M	12.1M
Common Stock Shares Outstanding	837.3K	1.5M	3.3M	5.5M	6.4M	6.7M
Liabilities And Stockholders Equity	265.7M	137.6M	136.5M	118.1M	135.8M	142.6M
Non Current Liabilities Total	18.7M	27.1M	28.1M	28.2M	32.4M	34.0M
Other Stockholder Equity	315.9M	331.4M	343.5M	347.7M	399.8M	419.8M
Total Liab	128.1M	91.5M	97.1M	90.4M	103.9M	109.1M
Property Plant And Equipment Gross	8.7M	6.3M	3.9M	3.6M	4.2M	4.4M
Total Current Assets	105.2M	59.9M	72.8M	61.9M	71.2M	74.7M
Short Term Debt	25.5M	3.9M	85K	4.3M	4.9M	3.6M
Other Current Assets	1.0M	8.0M	8.9M	5.6M	6.5M	6.8M
Common Stock	12.6K	3K	4K	1K	900.0	855.0
Net Tangible Assets	34.7M	(13.7M)	(24.5M)	(19.6M)	(17.7M)	(16.8M)
Non Currrent Assets Other	465K	766K	792K	2.2M	2.6M	2.7M
Intangible Assets	85.5M	70.6M	59.0M	52.5M	60.3M	35.8M
Property Plant Equipment	258.5K	8.7M	6.3M	3.9M	4.4M	4.7M
Other Liab	28.8M	15.9M	12.8M	13.4M	15.4M	12.2M
Other Assets	33.0K	465K	766K	792K	910.8K	956.3K
Net Receivables	28.2M	21.7M	28.9M	23.6M	27.2M	28.5M
Inventory	16.3M	10.8M	12.0M	12.6M	14.5M	15.3M
Non Current Liabilities Other	15.9M	12.8M	7.0M	4.5M	5.2M	4.9M
Long Term Debt	180K	14.3M	14.7M	10.9M	12.5M	9.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Aytu Stock Analysis

When running Aytu BioScience's price analysis, check to measure Aytu BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aytu BioScience is operating at the current time. Most of Aytu BioScience's value examination focuses on studying past and present price action to predict the probability of Aytu BioScience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aytu BioScience's price. Additionally, you may evaluate how the addition of Aytu BioScience to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC